All Pharma News
AVROBIO and Tectonic Therapeutic Announce Merger

AVROBIO and Tectonic Therapeutic Announce Merger
BUSINESSWIRE
30 Jan 2024
Share Share
Avrobio stops programs, halves head count and searches for exit

Avrobio stops programs, halves head count and searches for exit
Nick Paul Taylor FIERCE BIOTECH
12 Jul 2023
Share Share
AVROBIO to Explore Strategic Alternatives

AVROBIO to Explore Strategic Alternatives
BUSINESSWIRE
12 Jul 2023
Share Share
Novartis Buys Avrobio Gene Therapy for $88 Million

Novartis Buys Avrobio Gene Therapy for $88 Million
CONTRACT PHARMA
31 May 2023
Share Share
Novartis to buy Avrobio gene therapy for $88M, ending M&A rumor

Novartis to buy Avrobio gene therapy for $88M, ending M&A rumor
Nick Paul Taylor FIERCE BIOTECH
23 May 2023
Share Share
AVROBIO Announces Agreement to Sell Cystinosis Gene Therapy Program for $87.5M

AVROBIO Announces Agreement to Sell Cystinosis Gene Therapy Program for $87.5M
BUSINESSWIRE
22 May 2023
Share Share
AVROBIO Announces Data from Phase 1/2 Clinical Trial of Cystinosis at ASGCT

AVROBIO Announces Data from Phase 1/2 Clinical Trial of Cystinosis at ASGCT
BUSINESSWIRE
18 May 2023
Share Share
AVROBIO Reports First Quarter 2023 Financial Results

AVROBIO Reports First Quarter 2023 Financial Results
BUSINESSWIRE
11 May 2023
Share Share
Avrobio Reports Fourth Quarter and Fiscal Year 2022 Financial Results

Avrobio Reports Fourth Quarter and Fiscal Year 2022 Financial Results
BUSINESSWIRE
23 Mar 2023
Share Share
AVROBIO to Present Data from Lysosomal Disorder Gene Therapy Pipeline

AVROBIO to Present Data from Lysosomal Disorder Gene Therapy Pipeline
BUSINESSWIRE
09 Feb 2023
Share Share